BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castaño JAT, Hernández-Gonzalez I, Gallego N, Pérez-Olivares C, Ochoa Parra N, Arias P, Granda E, Acebo GG, Lago-Docampo M, Palomino-Doza J, López Meseguer M, Del Cerro MJ, Pah Consortium S, Valverde D, Lapunzina P, Escribano-Subías P. Customized Massive Parallel Sequencing Panel for Diagnosis of Pulmonary Arterial Hypertension. Genes (Basel) 2020;11:E1158. [PMID: 33007923 DOI: 10.3390/genes11101158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Xiao F, Qian Y, Wu B, Dong X, Lu Y, Cheng G, Wang L, Yan K, Yang L, Chen L, Kang W, Li L, Pan X, Wei Q, Zhuang D, Chen D, Yin Z, Yang L, Ni Q, Liu R, Li G, Zhang P, Li X, Peng X, Wang Y, Chen H, Ma X, Liu F, Cao Y, Huang G, Zhou W. Genetic architecture in neonatal intensive care unit patients with congenital heart defects: a retrospective study from the China Neonatal Genomes Project. J Med Genet 2022:jmedgenet-2021-108354. [PMID: 35595280 DOI: 10.1136/jmedgenet-2021-108354] [Reference Citation Analysis]
2 Pienkos S, Gallego N, Condon DF, Cruz-Utrilla A, Ochoa N, Nevado J, Arias P, Agarwal S, Patel H, Chakraborty A, Lapunzina P, Escribano P, Tenorio-Castaño J, de Jesús Pérez VA. Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension. Front Med (Lausanne) 2021;8:625763. [PMID: 33996849 DOI: 10.3389/fmed.2021.625763] [Reference Citation Analysis]
3 Welch CL, Chung WK. Channelopathy Genes in Pulmonary Arterial Hypertension. Biomolecules 2022;12:265. [DOI: 10.3390/biom12020265] [Reference Citation Analysis]
4 Cruz-utrilla A, Gallego N, Torrent-vernetta A, Guillén I, Escribano Subias MP, del Cerro Marín MJ. Prevalencia de variantes genéticas en la hipertensión arterial pulmonar tras la reparación de D-transposición de grandes vasos. Registro REHIPED. Revista Española de Cardiología 2022;75:449-50. [DOI: 10.1016/j.recesp.2021.11.003] [Reference Citation Analysis]
5 Elliott CG. Genetic Counseling and Testing in Pulmonary Arterial Hypertension. Methodist Debakey Cardiovasc J 2021;17:101-5. [PMID: 34326929 DOI: 10.14797/ZOQM5771] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gallego N, Cruz-Utrilla A, Guillén I, Bonora AM, Ochoa N, Arias P, Lapunzina P, Escribano-Subias P, Nevado J, Tenorio-Castaño J. Expanding the Evidence of a Semi-Dominant Inheritance in GDF2 Associated with Pulmonary Arterial Hypertension. Cells 2021;10:3178. [PMID: 34831401 DOI: 10.3390/cells10113178] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hernandez-Gonzalez I, Tenorio-Castano J, Ochoa-Parra N, Gallego N, Pérez-Olivares C, Lago-Docampo M, Palomino Doza J, Valverde D, Lapunzina P, Escribano-Subias P. Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease. Cells 2021;10:1488. [PMID: 34199176 DOI: 10.3390/cells10061488] [Reference Citation Analysis]
8 Machado RD, Southgate L. Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era. Genes (Basel) 2021;12:1798. [PMID: 34828405 DOI: 10.3390/genes12111798] [Reference Citation Analysis]
9 Qin X, Li T, Sun W, Guo X, Fang Q. Proteomic analysis of pulmonary arterial hypertension. Ther Adv Chronic Dis 2021;12:20406223211047304. [PMID: 34729151 DOI: 10.1177/20406223211047304] [Reference Citation Analysis]
10 Gallego-Zazo N, Cruz-Utrilla A, Del Cerro MJ, Ochoa Parra N, Blanco JN, Arias P, Lapunzina P, Escribano-Subias P, Tenorio-Castaño J. Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature. Genes (Basel) 2022;13:927. [PMID: 35627312 DOI: 10.3390/genes13050927] [Reference Citation Analysis]